Topic

Texas

A collection of 504 issues

Renewing Poteligeo (Mogamulizumab-kpkc) Approval with Cigna in Texas: 2025 Requirements, Timeline, and Appeal Options

Quick Answer: Renewing Your Poteligeo Coverage with Cigna in Texas Poteligeo (mogamulizumab-kpkc) requires annual renewal with Cigna, typically 30-60 days before your current authorization expires. Submit updated TNMB staging, pathology reports, flow cytometry results (for Sézary syndrome), proof of clinical benefit, and specialist consultation notes. Cigna reviews within 72 hours
6 min read

UnitedHealthcare's Coverage Criteria for Hetlioz (Tasimelteon) in Texas: What Counts as "Medically Necessary"?

Answer Box: Getting Hetlioz Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Hetlioz (tasimelteon) with strict medical necessity criteria. Coverage is limited to totally blind adults with Non-24-Hour Sleep-Wake Disorder or confirmed Smith-Magenis Syndrome patients (ages 3-15 for oral suspension, 16+ for capsules). Step therapy with melatonin is
6 min read

Renewing Rystiggo (Rozanolixizumab-noli) Approval with Humana in Texas: Complete Timeline and Documentation Guide

Answer Box: Renewing Rystiggo Coverage with Humana in Texas To renew Rystiggo (rozanolixizumab-noli) approval with Humana in Texas, start your renewal process 60-90 days before your current authorization expires. Submit updated MG-ADL scores showing continued benefit, complete treatment logs, and a physician letter documenting ongoing medical necessity. Use Humana'
6 min read